Portfolio company
ReSpindle
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops an artificial intelligence platform for IVF clinics to assess egg cell viability and detect chromosomal abnormalities through computer vision analysis.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Future Fertility
This company develops artificial intelligence software for oocyte quality assessment to assist fertility clinics and patients with reproductive treatment decisions.
VitruvianMD
This company develops AI-powered diagnostic software and microscope camera hardware for medical laboratories and fertility clinics to facilitate pathology testing and reproductive health.
Reticular
This company develops interpretable artificial intelligence models for embryo genetic screening and drug discovery to assist prospective parents and pharmaceutical researchers.
Imvitro
Imvitro develops an artificial intelligence platform for embryo selection to help fertility clinics improve success rates and transparency for IVF patients.
FemTech
This company provides artificial intelligence-powered fertility treatments and clinical care for patients experiencing infertility.
FertilAI
The company develops artificial intelligence software for fertility clinics to manage patient communication and clinical treatment planning for reproductive health procedures.
Vitra Labs
The company develops a stem cell platform to produce eggs for patients undergoing fertility treatments without the use of hormones or donor tissue.
Cercle
This company develops an artificial intelligence platform that analyses clinical data to provide personalised insights for women's healthcare providers and fertility clinics.
